Silexion Therapeutics
SLXN • XNAS
Silexion Therapeutics is a biological products, (no disgnostic substances) company trading on XNAS, led by CEO Ilan Hadar, with a market cap of $3.7M.
Market Cap$3.7M
CEOIlan Hadar
CountryUnited States of America
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
SLX
Silexion Therapeutics FAQ
Common questions about Silexion Therapeutics
Silexion Therapeutics is scheduled to report earnings for Q1 2026 on May 12, 2026.